NSG 6005 final exam UPDATED ACTUAL Questions and CORRECT
Answers
1. • Prescribing for
infants and chil-
dren
2. Pharmacokinet- what the body does to the drug (absorption, distribution, metabolism, excretion)
ics
3. Bioavailability issues important for drugs with narrow therapeutic ranges or sustained release
mechanism
4. half-life time required for amount of drug in body to decrease by 50%
5. First Pass Effect rapidly metabolized by liver, may have little if any desired action
(Metabolism)
6. adverse drug re- - any unexpected, unintended, undesired, or excessive response to a medication
action given at therapeutic dosages (as opposed to overdose)
- infants/young children: lack of studies in that population
- elderly: decrease in renal function
- teratogen causes type D ADR (ex lisinopril)
7. • Guidelines for
treatment and
education of
common dis-
eases
8. • Stepwise ap-
proach to drug
management
, 9. Prescribing for • Hyperlipidemia and increased LDL in preg. Woman drug of choice: bile acid
women during binding resins
their childbear- • Prescribing for women during childbirth years requires constant awareness of
ing years the possibility of: risk for silent bacterial / viral infections of the genitalia
10. • Teach-
ing regarding
of beclometha-
sone (QVAR) in-
halers
11. how to taper
medication
12. required labora-
tory monitoring
for drugs
13. anticholinergic manage symptoms: sip on liquids for dry mouth, sunglasses for photophobia,
drugs urinate prior to medication to reduce retention
14. Phenytoin moni- - requires a trough level, peak and trough are done to determine if it is in
toring therapeutic range
15. anorexiant pre- - addicting
scribing precau- - not to be used for more than 6 months
tions
16. • The clinical
characteristics of
medica-
tion-overuse
headaches
2/9
Answers
1. • Prescribing for
infants and chil-
dren
2. Pharmacokinet- what the body does to the drug (absorption, distribution, metabolism, excretion)
ics
3. Bioavailability issues important for drugs with narrow therapeutic ranges or sustained release
mechanism
4. half-life time required for amount of drug in body to decrease by 50%
5. First Pass Effect rapidly metabolized by liver, may have little if any desired action
(Metabolism)
6. adverse drug re- - any unexpected, unintended, undesired, or excessive response to a medication
action given at therapeutic dosages (as opposed to overdose)
- infants/young children: lack of studies in that population
- elderly: decrease in renal function
- teratogen causes type D ADR (ex lisinopril)
7. • Guidelines for
treatment and
education of
common dis-
eases
8. • Stepwise ap-
proach to drug
management
, 9. Prescribing for • Hyperlipidemia and increased LDL in preg. Woman drug of choice: bile acid
women during binding resins
their childbear- • Prescribing for women during childbirth years requires constant awareness of
ing years the possibility of: risk for silent bacterial / viral infections of the genitalia
10. • Teach-
ing regarding
of beclometha-
sone (QVAR) in-
halers
11. how to taper
medication
12. required labora-
tory monitoring
for drugs
13. anticholinergic manage symptoms: sip on liquids for dry mouth, sunglasses for photophobia,
drugs urinate prior to medication to reduce retention
14. Phenytoin moni- - requires a trough level, peak and trough are done to determine if it is in
toring therapeutic range
15. anorexiant pre- - addicting
scribing precau- - not to be used for more than 6 months
tions
16. • The clinical
characteristics of
medica-
tion-overuse
headaches
2/9
